Clinical Trials in Kusatsu, Shiga
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled121 locationsNCT06834347
Recruiting
Fabhalta Capsules Specified Drug-use Survey
C3 Glomerulopathy
Novartis Pharmaceuticals50 enrolled26 locationsNCT07156149